Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: 9 - The Real Truth

Sanofi Expands Insulin Savings Program To Cover All US Patients

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: SNY) Genzyme Corporation.

Benzinga · Sep 26, 2025

Three in four English hospitals failing to hit two cancer targets in league tables

Exclusive: Cancer experts declare ‘national emergency’ as hospitals miss targets on diagnosis and starting treatment

The Guardian - UK · Sep 14, 2025

Warning after cancer patients died following delays in getting life-saving emergency drugs

More than a dozen cancer patients have either died or become seriously ill after not getting rasburicase

The Independent UK · Sep 12, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Bruce Dickinson: 'I sounded like a wounded buffalo after cancer treatment'

Bruce Dickinson has opened up about his recovery from throat cancer treatment and how it impacted his voice.

BANG Premier · Sep 9, 2025

EXCLUSIVE: Hoth Therapeutics' Antisense Therapy Demonstrates Efficacy Against KIT-Driven Cancers

Hoth Therapeutics Inc. (NASDAQ:HOTH) on Tuesday announced combined findings from multiple preclinical programs evaluating its precision antisense candidate HT-KIT.

Benzinga · Sep 2, 2025

HCW Biologics' Shares Surge After Unveiling Next-Gen Cancer Immunotherapy Platform

HCW Biologics Inc. (NASDAQ:HCWB) stock is trading higher on Monday, with a session volume of 10.85 million compared to the average volume of 132.51K as per data from Benzinga Pro.

Benzinga · Aug 25, 2025

Thousands referred for liver cancer checks after on-the-spot scan

Some 112,831 people have had a mobile scan of their liver under the NHS scheme

The Independent UK · Aug 24, 2025

Read news from The Economist, FT, and more,
with one subscription

Treatment that can double bladder cancer survival rates available to 1,000 patients in England

People with disease that has spread have been found to live twice as long when given treatment hailed as ‘hopeful’

The Guardian - UK · Aug 20, 2025

Abortion drug could help reduce risk of breast cancer, group of medics says

Stigma around mifepristone is stopping studies, experts in reproductive health claim in Lancet opinion piece

The Guardian - UK · Aug 14, 2025

Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients

On Tuesday, Merck Co. Inc. (NYSE:MRK) released topline results from the Phase 3 KEYNOTE-905 trial (also known as EV-303) in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based chemotherapy.

Benzinga · Aug 12, 2025

IO Biotech's Combo Therapy For Skin Cancer Falls Just Short, Eyes FDA Talks Later This Year

IO Biotech (NASDAQ:IOBT) on Monday released topline results from the pivotal Phase 3 trial of its investigational, immune-modulatory, off-the-shelf therapeutic cancer vaccine, Cylembio (imsapepimut and etimupepimut, adjuvanted).

Benzinga · Aug 11, 2025

Three new cancer drugs approved for use for NHS Scotland

Three new treatments for cancer have been approved for use by the NHS in Scotland ...

The National (Scotland) · Aug 11, 2025

The new take-at-home drug that ‘could boost effectiveness of chemotherapy’

New medicine will spare some patients from more aggressive treatments

The Independent UK · Aug 10, 2025

‘Game-changing’ cancer vaccine trial to begin on NHS

The jab uses mRNA technology to train the immune system to fight cancerous cells

The Independent UK · Aug 7, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard · Aug 7, 2025

Patients to be fast-tracked on to new head and neck cancer vaccine trial

The jab uses mRNA technology to train the immune system to fight cancer.

Benzinga · Jul 28, 2025

Celcuity Stock Skyrockets On Breakthrough Trial Data For Heavily Pretreated Breast Cancer

Celcuity Inc. (NASDAQ:CELC) stock surged on Monday after the company reported topline results from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial, which evaluated gedatolisib plus fulvestrant with and without palbociclib versus fulvestrant.

Everybody Loves Your Money · Jul 25, 2025

9 DIY Remedies That Medical Boards Are Warning Against

DIY health hacks flood social media and blogs with promises of miracle cures and quick fixes. From homemade detox teas to sketchy dental work, these trends often spread faster than facts can catch up. But while some may seem harmless, medical boards across the country are issuing clear warnings.

Evening Standard · Jul 9, 2025

New technique hailed as ‘powerful double weapon’ against chemo hair loss

The method combines scalp cooling with a special lotion.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Jun 24, 2025

Alcohol labels should warn of cancer risk, urge health groups

Doctors and health experts have written a letter to Sir Keir Starmer urging the government to tackle a lack of awareness about the links between alcohol consumption and cancer

The Guardian - UK · Jun 21, 2025

Alcohol should have labels warning drinkers of cancer risks, charities say

Health organisations have written to Keir Starmer urging him to force drinks producers to include warnings

International Business Times UK · Jun 18, 2025

Banned in Britain, Still on US Shelves: Jolly Ranchers Pulled Over 'Cancer‑Causing' Ingredients

Jolly Rancher sweets have been pulled from UK shelves over ingredients linked to cancer risk. Here's why the US still allows them and what consumers need to know

The Independent UK · Jun 17, 2025

EPA will revisit Biden-era ban on the last type of asbestos used in US

The Environmental Protection Agency will reconsider a Biden administration ban on the last type of asbestos used in the United States

The Guardian - UK · Jun 16, 2025

UK-wide drug trial hailed as a ‘milestone’ in leukaemia treatment

Combination of two targeted drugs found to produce better outcomes and was more tolerable than chemotherapy

Evening Standard · Jun 15, 2025

New leukaemia treatment hailed as ‘milestone’ for patients

After five years, 94% of patients were alive, with no disease progression.

The Independent UK · Jun 15, 2025

‘Milestone’ treatment could reshape future leukaemia care

The Flair trial found that 94 per cent of patients who received the two targeted drugs were alive with no disease progression after five years

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Environmental Protection Agency

the University of Leeds

67 stories

SMC

66 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.